NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » GENFIT, LabCorp sign exclusive agreement to commercialise novel diagnostic test for liver disease » Belov

GENFIT, LabCorp sign exclusive agreement to commercialise novel diagnostic test for liver disease

NS Medical Devices is using cookies

GENFIT, LabCorp sign exclusive agreement to commercialise novel diagnostic test for liver disease. (Credit: Belova59 from Pixabay)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Science acquires PRIMA retinal implant technology from Pixium Vision

Provisio Medical secures FDA clearance for Provisio SLT IVUS System

Abzena unveils EpiScreen 2.0 platform for immunogenic assessment

EUROIMMUN, ALPCO-GeneProof partner on distribution of GeneProof PCR kits in EU

Blue Arbor secures FDA Breakthrough Device Designation for RESTORE System

Recommended Whitepaper